Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Clinical Trials Arena image

News from Clinical Trials Arena

Top Clinical Trials Arena News

Eli Lilly's Weight Loss Pill Clears Way During Latest Trial, Approval May Come Soon
Eli Lilly · San Antonio

Eli Lilly's Weight Loss Pill Clears Way During Latest Trial, Approval May Come Soon

63% Right coverage: 8 sources
Eli Lilly said on Tuesday that its daily weight loss pill helped patients lose weight, specifically those with obesity and Type 2 diabetes.See the Story
FDA Approves Coya Therapeutics’ Trial of COYA 302 for ALS
United States · United States

FDA Approves Coya Therapeutics’ Trial of COYA 302 for ALS

100% Center coverage: 2 sources
Coya Therapeutics has announced the acceptance by the US FDA of IND application for COYA 302, paving the way for a Phase II trial.The post FDA approves Coya Therapeutics’ trial of COYA 302 for ALS appeared first on Clinical Trials Arena.See the Story
Regeneron’s RNA Med for Muscle Disease Meets Trial Goals; FDA Filing Planned for Next Year

Regeneron’s RNA Med for Muscle Disease Meets Trial Goals; FDA Filing Planned for Next Year

100% Center coverage: 2 sources
Cemdisiran, a small interfering RNA drug that Regeneron Pharmaceuticals licensed from Alnylam Pharmaceuticals, met the goals of its pivotal test in generalized myasthenia gravis. The rare neuromuscular disease has several new therapies, but analysts see cemdisiran as having advantages over one particular class of drugs. The post Regeneron’s RNA Med for Muscle Disease Meets Trial Goals; FDA Filing Planned for Next Year appeared first on MedCity N…See the Story

Breaking News Topics Related to Clinical Trials Arena

Cancer icon

Cancer

Health icon

Health

United States icon

United States

Medical icon

Medical

United Kingdom icon

United Kingdom

News
For You
SearchBlindspotLocal